Umlobi: Roger Morrison
Usuku Lokudalwa: 21 Usepthemba 2021
Ukuvuselela Usuku: 1 Epreli 2025
Anonim
I-Isoniazid eneRifampicin: indlela yokusebenza kanye nemiphumela emibi - Impilo
I-Isoniazid eneRifampicin: indlela yokusebenza kanye nemiphumela emibi - Impilo

-Delile

I-Isoniazid ene-rifampicin isidakamizwa esisetshenziselwa ukwelashwa nokuvimbela isifo sofuba, futhi singahlotshaniswa nezinye izidakamizwa.

Leli khambi liyatholakala ezikhemisi kodwa lingatholwa kuphela ngokwethula incwadi kadokotela futhi kufanele lisetshenziswe ngokuqapha, ngenxa yokuphikisana nemiphumela engemihle elethwayo.

Isetshenziswa kanjani

Kuzo zonke izinhlobo zesifo sofuba samaphaphu namaphaphu, ngaphandle kwe-meningitis kanye neziguli ezingaphezu kwesisindo esingama-20 kg, kumele bathathe, nsuku zonke, imithamo ekhonjiswe etafuleni elilandelayo:

IsisindoIsoniazidI-RifampicinAmaphilisi
21 - 35 Kg200 mg300 mgIphilisi elilodwa lama-200 + 300
36 - 45 Kg300 mg450 mgIphilisi elilodwa elingu-200 + 300 nelinye elingu-100 + 150
Ngaphezulu kwama-45 Kg400 mg600 mgAmaphilisi amabili ka-200 + 300

Umthamo kufanele unikezwe ngomthamo owodwa, okungcono ekuseni esiswini esingenalutho, noma amahora amabili ngemuva kokudla. Ukwelashwa kufanele kwenziwe izinyanga eziyisithupha, kepha udokotela angashintsha umthamo.


Indlela yokusebenza

I-Isoniazid ne-rifampicin yizinto ezilwa namagciwane abanga isifo sofuba, esaziwa njenge Isifo sofuba iMycobacterium.

I-Isoniazid yinto evimbela ukuhlukana okusheshayo futhi iholele ekufeni kwe-mycobacteria, edala isifo sofuba, kanti i-rifampicin iyi-antibiotic evimbela ukuphindaphindeka kwamagciwane abucayi futhi yize inesenzo esilwa namagciwane amaningi, isetshenziswa kakhulu ekwelapheni uchoko nesifo sofuba.

Ngubani ongafanele asebenzise

Lo muthi akufanele usetshenziswe kubantu abaphikisana nanoma iyiphi into ekhona kwifomula, abantu abanezinkinga zesibindi noma izinso noma abantu abathatha imishanguzo engadala ushintsho esibindini.

Ngaphezu kwalokho, akunconywa ukuthi kusetshenziswe ezinganeni ezingaphansi kwama-20 kg wesisindo somzimba, abesifazane abakhulelwe noma labo abancelisayo.

Imiphumela emibi engaba khona

Imiphumela emibi kakhulu engenzeka ngokusetshenziswa kwalo muthi ukulahleka kwemizwa emaphethelweni njengezinyawo nezandla kanye nezinguquko esibindi, ikakhulukazi kubantu abaneminyaka engaphezu kwengama-35 ubudala.I-Neuropathy, evame ukubuyiselwa emuva, ivame kakhulu kubantu abangondlekile, izidakwa noma abantu asebavele banezinkinga zesibindi nalapho bevezwa yimithamo ephezulu ye-isoniazid.


Ngaphezu kwalokho, ngenxa yokuba khona kwe-rifampicin, ukulahlekelwa isifiso sokudla, isicanucanu, ukuhlanza, isifo sohudo nokuvuvukala kwamathumbu.

Isincomo Sethu

I-hip dysplasia: kuyini, kanjani ukukhomba nokwelashwa

I-hip dysplasia: kuyini, kanjani ukukhomba nokwelashwa

I-Hip dy pla ia enganeni, eyaziwa nangokuthi i-congenital dy pla ia noma i-dy pla ia yentuthuko yenyonga, inguquko lapho ingane izalwa inokulingana okungaphelele phakathi kwe-femur nethambo le-hip, el...
Iresiphi yesinkwa esiphelele sabantu abanesifo sikashukela

Iresiphi yesinkwa esiphelele sabantu abanesifo sikashukela

Le ire iphi ye inkwa e in undu inhle nge ifo ika hukela ngoba ayina hukela owengeziwe futhi i ebenzi a ufulawa ophelele woku anhlamvu uku iza ukulawula inkomba ye-glycemic.I inkwa wukudla okungadliwa ...